Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.2B
1-Year Return 41.49%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Return
+5.62%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$52.5B
AUM Growth
-$68.7M
Cap. Flow
-$1.87B
Cap. Flow %
-3.55%
Top 10 Hldgs %
8.03%
Holding
3,774
New
423
Increased
1,688
Reduced
1,158
Closed
474

Top Buys

1
CVS icon
CVS Health
CVS
+$349M
2
NKE icon
Nike
NKE
+$280M
3
HD icon
Home Depot
HD
+$262M
4
AMZN icon
Amazon
AMZN
+$167M
5
MA icon
Mastercard
MA
+$166M

Sector Composition

1 Technology 13.83%
2 Healthcare 12.18%
3 Financials 11.43%
4 Industrials 8.95%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ESEA icon
3001
Euroseas
ESEA
$438M
$236K ﹤0.01%
19,352
+292
+2% +$3.56K
OREX
3002
DELISTED
Orexigen Therapeutics, Inc.
OREX
$236K ﹤0.01%
54,950
-183,160
-77% -$787K
SBLX
3003
StableX Technologies, Inc. Common Stock
SBLX
$3.76M
$234K ﹤0.01%
9
OCUL icon
3004
Ocular Therapeutix
OCUL
$2.22B
$234K ﹤0.01%
+47,300
New +$234K
PER
3005
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$233K ﹤0.01%
89,555
+76,555
+589% +$199K
ABB
3006
DELISTED
ABB Ltd.
ABB
$232K ﹤0.01%
11,700
-330,500
-97% -$6.55M
MNDO icon
3007
Mind CTI
MNDO
$24.2M
$231K ﹤0.01%
108,400
-22,800
-17% -$48.6K
VALU icon
3008
Value Line
VALU
$363M
$231K ﹤0.01%
14,100
+800
+6% +$13.1K
OIG
3009
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$230K ﹤0.01%
1,140
-803
-41% -$162K
ASGN icon
3010
ASGN Inc
ASGN
$2.3B
$229K ﹤0.01%
6,194
-325,000
-98% -$12M
NRT
3011
North European Oil Royalty Trust
NRT
$48.5M
$227K ﹤0.01%
+23,800
New +$227K
DRNA
3012
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$227K ﹤0.01%
75,600
+45,700
+153% +$137K
OTIV
3013
DELISTED
OTI On Track Innovations Ltd
OTIV
$226K ﹤0.01%
245,931
+32,331
+15% +$29.7K
GROW icon
3014
US Global Investors
GROW
$31.9M
$225K ﹤0.01%
132,600
+17,300
+15% +$29.4K
CYCC icon
3015
Cyclacel Pharmaceuticals
CYCC
$14.1M
$224K ﹤0.01%
+1
New +$224K
EPE
3016
DELISTED
EP Energy Corporation
EPE
$224K ﹤0.01%
43,200
-211,217
-83% -$1.1M
CTO
3017
CTO Realty Growth
CTO
$543M
$223K ﹤0.01%
+17,315
New +$223K
CBAY
3018
DELISTED
Cymabay Therapeutics
CBAY
$223K ﹤0.01%
128,300
+17,300
+16% +$30.1K
MCRN
3019
DELISTED
Milacron Holdings Corp.
MCRN
$222K ﹤0.01%
15,300
-4,000
-21% -$58K
AVXS
3020
DELISTED
AveXis, Inc. Common Stock
AVXS
$222K ﹤0.01%
+5,831
New +$222K
ARCW
3021
DELISTED
ARC Group Worldwide, Inc
ARCW
$221K ﹤0.01%
96,200
+15,600
+19% +$35.8K
CGRN
3022
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$220K ﹤0.01%
15,951
+2,035
+15% +$28.1K
FCRE
3023
DELISTED
FC Global Realty Incorporated Common Stock
FCRE
$220K ﹤0.01%
174,840
+5,160
+3% +$6.49K
APAM icon
3024
Artisan Partners
APAM
$3.33B
$219K ﹤0.01%
7,900
-30,500
-79% -$846K
IDXG
3025
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$218K ﹤0.01%
6,614
+29
+0.4% +$956